Reau, N., Muir, A. J., Pockros, P., Reddy, R. K., Pedrosa, M., Larsen, L., … Howell, C. (2015). High SVR Rates Among US Patients Regardless of Race or Ethnicity in HCV GT1 Patients Receiving the Label-Recommended Regimen of Ombitasvir/Paritaprevir/r+Dasabuvir±Ribavirin: Integrated Safety and Efficacy Analysis. In American Journal of Gastroenterology (Vol. 110, pp. S859–S859). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.14309/00000434-201510001-02038

Reau, Nancy, Andrew J. Muir, Paul Pockros, Rajender K. Reddy, Marcos Pedrosa, Lois Larsen, Jeffrey Enejosa, and Charles Howell. “High SVR Rates Among US Patients Regardless of Race or Ethnicity in HCV GT1 Patients Receiving the Label-Recommended Regimen of Ombitasvir/Paritaprevir/r+Dasabuvir±Ribavirin: Integrated Safety and Efficacy Analysis.” In American Journal of Gastroenterology, 110:S859–S859. Ovid Technologies (Wolters Kluwer Health), 2015. https://doi.org/10.14309/00000434-201510001-02038.

Reau N, Muir AJ, Pockros P, Reddy RK, Pedrosa M, Larsen L, et al. High SVR Rates Among US Patients Regardless of Race or Ethnicity in HCV GT1 Patients Receiving the Label-Recommended Regimen of Ombitasvir/Paritaprevir/r+Dasabuvir±Ribavirin: Integrated Safety and Efficacy Analysis. In: American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2015. p. S859–S859.

Reau, Nancy, et al. “High SVR Rates Among US Patients Regardless of Race or Ethnicity in HCV GT1 Patients Receiving the Label-Recommended Regimen of Ombitasvir/Paritaprevir/r+Dasabuvir±Ribavirin: Integrated Safety and Efficacy Analysis.” American Journal of Gastroenterology, vol. 110, Ovid Technologies (Wolters Kluwer Health), 2015, pp. S859–S859. Crossref, doi:10.14309/00000434-201510001-02038.

Reau N, Muir AJ, Pockros P, Reddy RK, Pedrosa M, Larsen L, Enejosa J, Howell C. High SVR Rates Among US Patients Regardless of Race or Ethnicity in HCV GT1 Patients Receiving the Label-Recommended Regimen of Ombitasvir/Paritaprevir/r+Dasabuvir±Ribavirin: Integrated Safety and Efficacy Analysis. American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2015. p. S859–S859.